 |
|
|
|
 |
egories |
 |
 |
New Addition |
 |
|
|
 |
Details: |
 |
|
|
Researches and develops biopharmaceutical products which address the role of blood and blood vessels in the prevention and treatment of diseases by inhibiting growth or enhancing bioavailability of drugs. Based in Rockville, Maryland. (Nasdaq: ENMD)
|
| URL: |
|
| Title: |
|
| Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - EntreMed, Inc.. Researches and develops biopharmaceutical products which address the role of blood and blood vessels in the prevention and treatment of diseases by inhibiting growth or enhancing bioavailability of drugs. |
| Specialized in: |
|
|
 |
|
 |
GenPhar (Popularity: ): Specializes in viral diagnostics, vaccines, and cancer therapy. Includes current research, news releases and contact information.
Pharmos Corporation (Popularity: ): Develops and commercializes products for the central nervous system (CNS), neurological, ophthalmic and other healthcare markets.
BioRexis Pharmaceutical Corp. (Popularity: ): Company with proprietary protein technology for carrier to enhance half-life and efficacy, fused peptide in therapeutic applications, and yeast host ...
Cue Biotech Inc. (Popularity: ): Company focusing on G-protein coupled receptor signaling as targets for therapeutic products. Includes corporate data, partnering and technology overviews, with ...
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
Generex Biotechnology (Popularity: ): Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
GlycoTech Corporation (Popularity: ): Research glycobiology company developing diagnostics and therapeutics for cancer and inflammatory diseases based on the interaction of glycoconjugates and their ...
Lybradyn: Microbial Natural Products (Popularity: ): Focused on discovering and developing natural products from living organisms to serve the pharmaceutical and fine chemical industries. Includes explanation ...
|
 |
Popular Sites |
 |
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
GenPhar (Popularity: ): Specializes in viral diagnostics, vaccines, and cancer therapy. Includes current research, news releases and contact information.
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Cue Biotech Inc. (Popularity: ): Company focusing on G-protein coupled receptor signaling as targets for therapeutic products. Includes corporate data, partnering and technology overviews, with ...
BioRexis Pharmaceutical Corp. (Popularity: ): Company with proprietary protein technology for carrier to enhance half-life and efficacy, fused peptide in therapeutic applications, and yeast host ...
|
 |
Related Press |
 |
Cord Blood America Supports Trend From New York, California for States to Inform Parents of the Advantages of Umbilical Cord Blood Storage (Popularity: ): Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on ...
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases (Popularity: ): Bayer HealthCare (NYSE: BAY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that the companies have entered into a collaboration ...
Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM) (Popularity: ): Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it submitted a Marketing Authorization Application (MAA) to the ...
DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease (Popularity: ): Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety ...
Pregnancy and Are You Getting Enough Vitamins and Nutrients? (Popularity: ): Are you getting enough vitamins and nutrients in your pre-natal vitamin? Or, have you ever wondered what exactly all of ...
|
 |
Related Articles |
 |
|
|
 |
|
 |
| |
| | |
|
|
|
© 2003-2008, ABC-Directory.Com. All Rights Reserved
|
|
|
 |
|
 |
|